NYSE: NVRO

Nevro Corp Stock Forecast, Predictions & Price Target

The consensus among 11 Wall Street analysts covering (NYSE: NVRO) stock is to Hold NVRO stock.

Out of 11 analysts, 1 (9.09%) are recommending NVRO as a Strong Buy, 3 (27.27%) are recommending NVRO as a Buy, 6 (54.55%) are recommending NVRO as a Hold, 0 (0%) are recommending NVRO as a Sell, and 1 (9.09%) are recommending NVRO as a Strong Sell.

If you're new to stock investing, here's how to buy Nevro stock.

(NYSE: NVRO) Nevro's forecast annual revenue growth rate of 2.74% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 5.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 6.49%.

Nevro's revenue in 2023 is $422,842,000.On average, 8 Wall Street analysts forecast NVRO's revenue for 2023 to be $15,148,922,190, with the lowest NVRO revenue forecast at $15,114,345,943, and the highest NVRO revenue forecast at $15,210,326,710. On average, 8 Wall Street analysts forecast NVRO's revenue for 2024 to be $15,996,637,650, with the lowest NVRO revenue forecast at $15,648,014,939, and the highest NVRO revenue forecast at $16,745,150,054.

In 2025, NVRO is forecast to generate $17,357,203,947 in revenue, with the lowest revenue forecast at $16,810,211,329 and the highest revenue forecast at $18,557,886,778.

According to 11 Wall Street analysts that have issued a 1 year NVRO price target, the average NVRO price target is $27.27, with the highest NVRO stock price forecast at $57.00 and the lowest NVRO stock price forecast at $15.00.

On average, Wall Street analysts predict that Nevro's share price could reach $27.27 by Nov 3, 2024. The average Nevro stock price prediction forecasts a potential upside of 57.47% from the current NVRO share price of $17.32.

(NYSE: NVRO) forecast ROE is N/A, which is considered weak.